A family of structurally related, Na ' /CI--dependent plasma-mernbranc transporters catalyze the uptake of several neurotransmitters, osmolytes and other metabolites into cells. Four different members of this transporter family have heen cloned from mamiiialian sources which all transport 4-aminobutyric acid (GABA) but differ in their pharmacological profiles and in thcir tissue distribution. We report on the cloning, sequencing and functional expression of a transporkr for GARA and /]Lalanine from the electric lobe of Torpedo. According to similarily of amino acid sequcnce (77 % identity), pharrnacological properties, and tissue distribution (nervous-system-specific), it appcars to be the counterpart of thc [Ialanine-sensitive GARA transporter, GAT-BIGAT-3IGAT4, previously cloned from rat and mouse. The identification of another GABA transportcr isoforrn from Torpedo (after the rccent characterization of a Torpedo GAT-1 transporter) indicatcs that GABA-(ransporter isoforms arc phylogenetically ancient and arose before the divergence of vertebrates. Sequence comparison between isofunctionul transporters from evolutionarily distant species aids in the identification of amino acid residucs that are critical for functional specificity. The expression of transporters for GARA and [hlanine raises questions regarding the unidentified physiological role of thesc amino acids in Torpedo electric lobe.Ke,ywwds: 4-arninobutyric acid ; jl-alanine ; transporter; Torp& ; plasma membrane. Plasma membrane bansporters driven by a Na' gradient are responsible for the removal of most neurotransmitlers from the synaptic cleft and thus for the controlled termination of synaptic signals. The modulation of their activity by pharmacological agents or by drugs of abuse can profoundly affect synaptic transmission. Some transporters [e.g., Lhosc for glutamate, 4-aminohutyric acid (GABA) and dopamine] have been shown to function also in reverse under conditions of energy deprivation or under the influence of drugs, leading to the non-vesicular release of neurotransmitter [I -31. Transporter-nicdiatcd release of &lu-tamate, for example, is believed to be an important pathogenetic mechanism i n hrain ischemia, anoxia, or epilepsy.Since 1990, molecular cloning has led to the characterkdtion of two neuro(ratisniitter-transporter families. Members of the first family 141 transport GABA, noradrenaline, dopamine, scrotonin, glycine, prolinc, [I-alanine, taurine, betaine and creatine, whercas carriers for glutamate, aspartate and several neutral amino acids constitute a second family 15-81, Both families are driven by a Na' griidient but differ i n their dependence on additional ions and have no significant sequcncc similarity. Although the characterization of the GABA/noradrenaline transporter family originatcd froin the study of neurotransmission, it has turned out that their physiological roles are not restricted to this func- tion. Ainong its members are carricrs for taurine [9][10][11], bctaine [12, 131, /Lalanine r14-161 and crcatine r17, 1x...